Back to search

Belgium· BE-AMP-SAM158042-00

Robinul-Neostigmine 0.5 mg/ml - 2.5 mg/ml

A glycopyrronium bromid product containing neostigmine metilsulfate, registered in Belgium by Eumedica Pharmaceuticals. The same ATC class is registered in 12 of our 19 countries.

ATC A03AB02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedRobinul-Neostigmine 0.5 mg/ml - 2.5 m…ATCA03AB02REGISTER NO.BE-AMP-SAM158042-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Glycopyrronium bromid is registered in 12 of 19 countries.

Countries holding a registration under ATC A03AB02 (glycopyrronium bromid), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Glycopyrronium bromid · ATC A03AB02

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Neostigmine Metilsulfate
Manufacturer
Eumedica Pharmaceuticals
Country
Belgium (BE)
ATC code
A03AB02
ATC class
Glycopyrronium bromid
Defined daily dose
3 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    1113323

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Glycopyrronium bromid in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glycopyrronium bromid products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Neostig, Normastigmin
  • Cyprus · Neostigmine Cooper
  • Czechia · Syntostigmin
  • Germany · Neostig, Neostigmin Panpharma
  • Spain · Neostigmina Braun
  • France · Néostigmine Renaudin, Prostigmine
  • United Kingdom (Northern Ireland) · Neostigmine Methylsulfate Bp Hameln Pharma
  • Greece · Neostigmine Cooper
  • Croatia · Neostigmin Panpharma
  • Hungary · Neostigmine Kalceks, Stigmosan
  • Latvia · Neostigmine Kalceks
  • Netherlands · Neostigminemethylsulfaat Cf, Prostigmin
  • Poland · Polstigminum
  • Portugal · Neostigmina Braun
  • Romania · Miostin
  • Sweden · Neostigmin Unimedic Pharma Ab
  • Slovakia · Syntostigmin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4fc3439a-7f77-473f-804f-82f3c5b56f9f
GET /v1/drugs/4fc3439a-7f77-473f-804f-82f3c5b56f9f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Robinul-Neostigmine 0.5 mg/ml - 2.5 mg/ml",
  "name_fr": "Robinul-Neostigmine 0.5 mg/ml - 2.5 mg/ml",
  "name_nl": "Robinul-Neostigmine 0.5 mg/ml - 2.5 mg/ml",
  "amp_code": "SAM158042-00",
  "strengths": [
    "2.5000",
    "0.5000",
    "23.1000"
  ],
  "pack_count": 1,
  "substances": [
    "Neostigmine Metilsulfate",
    "Glycopyrronium Bromide",
    "Sodium Hydroxide",
    "Sodium Phosphate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Glycopyrronium Bromide",
  "authorisation_numbers": [
    "BE158042"
  ]
}

See everything about glycopyrronium bromid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.